文献速递MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

种系易感变异发生于所有年龄的骨髓增生异常综合征患者

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
PubMed 文献 · Blood · 2022-01-01

本研究对404例接受异基因造血干细胞移植的骨髓增生异常综合征(MDS)患者及其相关供者进行增强全外显子测序,分析233个基因的胚系变异。在404例患者中28例(7%)检出致病/可能致病变异,分布于所有年龄组;携带者发生高级别MDS的比例高于未携带者(43% vs 25%;P = .04)。作者认为该高频检出支持对所有MDS患者 regardless of age 进行综合胚系基因检测。

要点

  • 404例MDS患者中28例(7%)检出致病/可能致病的种系变异,分布于所有年龄组。
  • 携带种系变异者发生高级别MDS的比例高于未携带者(43% vs 25%;P = .04)。
  • 作者认为该高频检出支持对所有MDS患者无论诊断年龄均进行综合种系基因检测。

核心结论

  • 404例MDS患者中28例(7%)检出致病/可能致病的种系变异,存在于所有年龄组。
  • 作者认为该高频检出支持对所有MDS患者无论诊断年龄均进行综合种系基因检测。

研究设计与样本

  • 对404例MDS患者及其相关供者在异基因造血干细胞移植前的外周血样本进行增强全外显子测序。
  • 分析并解读233个基因中的单核苷酸变异和拷贝数变异。
  • 通过患者及相关供者均存在该变异或既往仅见为种系等位基因来确定种系状态。

主要发现

  • 404例MDS患者中28例(7%)检出致病/可能致病的种系变异,存在于所有年龄十分位组。
  • 携带致病/可能致病变异者发生高级别MDS的比例高于未携带者(43% vs 25%;P = .04)。
  • 携带与不携带种系变异患者之间的结局参数无统计学显著差异,但该分析把握度不足。
  • 年龄小于40岁患者中5例检出骨髓衰竭综合征基因的致病/可能致病变异;年龄大于40岁患者中检出DDX41(n = 4)、端粒生物学障碍基因(n = 2)和一般肿瘤易感基因(n = 17)的变异。
  • 若纳入推测的种系变异,致病/可能致病变异的检出率增至11%;再加入可疑的意义未知变异,进一步升至12%。

临床怎么用

  • 作者认为该高频检出支持对所有MDS患者无论诊断年龄均进行综合种系基因检测。

局限性

  • 携带与不携带种系变异患者之间的结局参数分析把握度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The frequency of pathogenic/likely pathogenic (P/LP) germ line variants in patients with myelodysplastic syndrome (MDS) diagnosed at age 40 years or less is 15% to 20%. However, there are no comprehensive studies assessing the frequency of such variants across the age spectrum. We performed augmented whole-exome sequencing of peripheral blood samples from 404 patients with MDS and their related donors before allogeneic hematopoietic stem cell transplantation. Single-nucleotide and copy number variants in 233 genes were analyzed and interpreted. Germ line status was established by the presence of a variant in the patient and related donor or for those seen previously only as germ line alleles. We identified P/LP germ line variants in 28 of 404 patients with MDS (7%), present within all age deciles. Patients with P/LP variants were more likely to develop higher-grade MDS than those without (43% vs 25%; P = .04). There was no statistically significant difference in outcome parameters between patients with and without a germ line variant, but the analysis was underpowered. P/LP variants in bone marrow failure syndrome genes were found in 5 patients aged less than 40 years, whereas variants in DDX41 (n = 4), telomere biology disorder genes (n = 2), and general tumor predisposition genes (n = 17) were found in patients aged more than 40 years. If presumed germ line variants were included, the yield of P/LP variants would increase to 11%, and by adding suspicious variants of unknown significance, it would rise further to 12%. The high frequency of P/LP germ line variants in our study supports comprehensive germ line genetic testing for all patients with MDS regardless of their age at diagnosis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Feurstein S, Trottier AM, Estrada-Merly N, et al. Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood. 2022. PMID: 35969835. doi:10.1182/blood.2022015790

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。